On the afternoon of June 19th, at the 8th China and World Pharmaceutical Entrepreneurs Summit, Sichuan Xieli Pharmaceutical Co., Ltd. was honorably shortlisted and awarded the honor of being the most growing enterprise. As an authoritative event in the industry, this conference released the 2017 Top 100 Pharmaceutical Internationalization Enterprises List and held a grand award ceremony at the conference site. The summit forum was organized by the China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products, Europe Bowen Exhibition Consulting Co., Ltd., and co organized by Shanghai Bohua International Exhibition Co., Ltd.

    As a star enterprise in the segmented field of raw materials, Xieli Pharmaceutical has received high attention from industry colleagues and relevant regulatory departments. Xieli Pharmaceutical adheres to the combination of internationalization strategy and localization perspective, and in recent years, its products have been continuously exported to Europe, America, Japan, South America and other places, occupying a place in the international drug supply chain system. The future is a long and arduous task. Currently, the company is continuously accumulating in technology research and development and resource integration, and the pace of internationalization is accelerating. In the future, more products with core competitiveness will be promoted to the world.

    At the meeting, Meng Dongping, Vice President of the China Chamber of Commerce for the Import and Export of Medical and Health Products, stated that the internationalization level of the industry depends on the achievements of individual enterprises active in it: large-scale export of preparations to standardized markets, overseas mergers and acquisitions reaching historic highs, and the pace of high-end international certification accelerating. In 2016, the internationalization momentum of Chinese pharmaceutical enterprises remained unchanged, and new achievements were constantly presented, closely interacting with the international pharmaceutical market through various forms.

    The power of role models is infinite. The Chamber of Commerce aims to raise the international awareness and influence of pharmaceutical internationalization leading enterprises through the selection of pharmaceutical companies silently working on the internationalization path through the Top 100 Enterprises, and set an industry benchmark for China's pharmaceutical internationalization strategy.

    Mr. Lv Yonghui, President of Zhejiang Pharmaceutical Co., Ltd., and Mr. Guo Bin, Chairman of Zhejiang Chemical Import and Export Co., Ltd., presented awards to the award-winning enterprises on stage

List of award-winning enterprises

     The selection of China's top 100 international pharmaceutical enterprises began in 2016 and was widely recognized by pharmaceutical companies after the release of the selection results last year, generating a wide social influence. In 2017, three awards were set for the selection of the top 100 international enterprises, namely high-quality suppliers and partners in the international market (top 60), leading enterprises in the internationalization of preparations (top 20), and the most growing enterprises (top 20).